Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.70 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.70 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.70 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.70 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.68 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.67 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.67 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15226209 | 0.91 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2552454 | 0.91 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2168191 | 0.90 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL425155 | 0.90 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL5846586 | 0.90 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL24211446 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2724554 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2635506 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL4948478 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL17745011 | 0.88 | SLC28A1 (0.67) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240240250-A1 | SYNTHESIZING BARCODING SEQUENCES UTILIZING PHASE-SHIFT BLOCKS AND USES THEREOF | BIO RAD LABORATORIES INC (US) | 2024-07-18 | — | — | US | disclosed |
| CN-110770356-B | MDA using bead oligonucleotides | 生物辐射实验室股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-113166807-B | Nucleotide sequence generation by co-localization of barcode beads in partitions | 生物辐射实验室股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20240093268-A1 | MDA USING BEAD OLIGONUCLEOTIDE | BIO RAD LABORATORIES INC (US) | 2024-03-21 | — | — | US | disclosed |
| US-11926871-B2 | Synthesizing barcoding sequences utilizing phase-shift blocks and uses thereof | BIO-RAD LABORATORIES, INC. (US) | 2024-03-12 | — | — | US | disclosed |
| US-11905551-B2 | MDA using bead oligonucleotide | BIO-RAD LABORATORIES, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| WO-2023244608-A1 | USE OF HOMOLOGOUS RECOMBINASE TO IMPROVE EFFICIENCY AND SENSITIVITY OF SINGLE CELL ASSAYS | BIO-RAD LABORATORIES, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023235317-A1 | METHODS AND HYDROGEL COMPOSITIONS FOR PARTITIONING BIOLOGICAL SAMPLES | BIO-RAD LABORATORIES, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-20230383332-A1 | METHODS AND HYDROGEL COMPOSITIONS FOR PARTITIONING BIOLOGICAL SAMPLES | BIO RAD LABORATORIES INC (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230323435-A1 | METHODS AND COMPOSITIONS FOR MAXIMUM RELEASE OF OLIGONUCLEOTIDES | BIO-RAD LABORATORIES, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20170198345-A1 | SYNTHESIZING BARCODING SEQUENCES UTILIZING PHASE-SHIFT BLOCKS AND USES THEREOF | BIO-RAD LABORATORIES, INC. | 2017-07-13 | — | — | US | disclosed |
| US-8025961-B2 | Liquid composition for metachromatic members, and metachromatic member set making use of the same | THE PILOT INK CO., LTD. (JP) | 2011-09-27 | — | — | US | disclosed |
| US-7632564-B2 | Liquid composition for metachromatic members, and metachromatic member set making use of the same | THE PILOT INK CO., LTD. (JP) | 2009-12-15 | — | — | US | disclosed |
| US-20090071370-A1 | LIQUID COMPOSITION FOR METACHROMATIC MEMBERS, AND METACHROMATIC MEMBER SET MAKING USE OF THE SAME | THE PILOT INK CO., LTD. (JP) | 2009-03-19 | — | — | US | disclosed |
| EP-1600482-A1 | Liquid composition for metachromatic members, and its use | THE PILOT INK CO., LTD. (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-20050260362-A1 | Liquid composition for metachromatic members, and metachromatic member set making use of the same | THE PILOT INK CO., LTD. (JP) | 2005-11-24 | — | — | US | disclosed |
| EP-0633786-A4 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS. | CRYOPHARM CORP (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0633786-A1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | BAXTER INTERNATIONAL INC. (US) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993014791-A2 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | CRYOPHARM CORPORATION (US) | 1993-08-05 | — | — | WO | disclosed |
| US-4418059-A | HALO-DEOXYURIDINE-BILE ACID ESTERS, ANTITUMOR AGENTS | MONTEFIORE MEDICAL CENTER (US) | 1983-11-29 | — | — | US | disclosed |